Clinical
In addition to offering EMRAM and other models, HIMSS can support healthcare organizations in achieving digital maturity, says Jill Seys, senior director for North America analytics at HIMSS.
Peer-reviewed medical research, published by the New England Journal of Medicine and the JAMA Network, will be accessible during patient encounters on the company's AI-enabled care platform.
Greg O'Neill, director of patient education at ChristianaCare, says artificial intelligence can help make messaging about meds more patient-friendly, with clear instructions to ensure care plan adherence.
The HIMSS Executive Connect program's small group of leaders fosters deep connections enabling them to sharpen leadership skills, share challenges and co-create solutions, says UVA Health CTO Zeb Elliott.
A HIMSS-NHIT partnership gives students AI training and hands-on experience through actual healthcare projects. Tom Leary, HIMSS senior vice president and head of government relations, and Luis Belen, NHIT CEO, explain.
Brenda Hood, client experience analyst at HealtHIE Nevada, says fragmented systems hinder care in tribal regions. Seamless data exchange is essential to closing care gaps and improving access to treatment.
Leaders from CMS, the VA and the HHS Office of Civil Rights discuss new frameworks, strategies and rule changes that will impact healthcare stakeholders. HIMSS Senior VP Tom Leary, its head of government relations, explains more.
Yearly Global Conference visits enable in-person meetings and perspective sharing that deepen connection, especially among the 75% of HIMSS members involved in its 22 communities, according to HIMSS' Tammy Kwiatkoski.
Healthcare organizations should be strategic about bidirectional data exchange opportunities to reduce duplication and enhance the efficiency of data pipelines, says J. Josh Wilda, University of Iowa Health Care's AVP for information systems and CIDO.
Clinicians using one vendor's algorithm found lung squamous cell carcinoma misdiagnoses, influencing treatment decisions and patient outcomes. The company's chief clinical officer walks through the JAMA study.